Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAn eye twitch — that involuntary, repetitive flickering of the eyelid — is not listed as a known side effect of Wegovy (semaglutide) in its UK prescribing information. Most people who notice eye twitching while taking Wegovy are experiencing a common, benign phenomenon called myokymia, which has many everyday causes and is very rarely connected to a specific medicine. That said, any new or persistent symptom that starts after beginning a prescription medicine deserves a proper look, and this page walks through what the evidence actually shows. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The medical name for a twitching eyelid is myokymia. It is caused by spontaneous electrical activity in the orbicularis oculi muscle, the ring of muscle that closes the eyelid. Almost everyone experiences it occasionally, and in the vast majority of cases it resolves within a few days without any treatment at all.
The trigger is rarely a single drug. Caffeine, sleep debt, screen time, stress, dry eyes, alcohol and low magnesium are the most commonly cited culprits in the clinical literature. When someone notices a new twitch after starting a medicine, the timing naturally prompts the question, but timing alone does not confirm cause.
It is worth reading the NHS patient-level guidance on semaglutide, which lists the side effects observed in Wegovy's clinical trials and post-marketing surveillance. Eye twitching does not appear among them. That is not a guarantee that no individual will ever experience it, but it does mean the signal is not one regulators or trialists have identified as a pattern linked to the medicine.
Wegovy works by mimicking GLP-1, a gut hormone that slows gastric emptying and reduces appetite. The first weeks of treatment often bring nausea, reduced food intake and, for some people, mild dehydration from early gastrointestinal symptoms. Fatigue is also common as the body adjusts.
Each of those things, independently, can provoke or worsen an eyelid twitch. If you are sleeping less well, eating less, drinking less fluid or feeling more fatigued than usual, the muscle activity behind myokymia can pick up. The connection, where it exists, is probably indirect rather than a direct pharmacological effect of semaglutide on the eye muscles.
For a broader picture of how the medicine interacts with other body systems, the page covering Wegovy's effects on the eyes goes into more detail on what is and is not documented. There is also a separate page on Wegovy and eyesight changes if your concern relates to vision rather than the eyelid muscle itself.
A twitch that lasts a few days and then stops is almost always benign myokymia. The situations that call for prompt medical review are different in character. Tell your GP or prescriber promptly if the twitching has persisted for more than two to three weeks without a break, if it has spread to other muscles in your face, if your eyelid is actually closing fully and involuntarily (which would suggest blepharospasm rather than myokymia), or if you have any accompanying change in vision.
Vision changes in a clinical context are taken seriously. The January 2026 MHRA Drug Safety Update on GLP-1 medicines focused primarily on pancreatitis, but the MHRA's Yellow Card scheme remains open for reporting any suspected side effect (including eye symptoms) that a patient or healthcare professional believes may be linked to a medicine. Reporting does not confirm causation; it contributes to the ongoing safety monitoring of newer medicines.
If you want to report a suspected side effect or check current MHRA safety communications, the MHRA Yellow Card portal is the right starting point. You can also find information about known Wegovy side effects in NHS guidance on semaglutide, which is updated as new safety data emerges.
Rest, hydration and cutting back on caffeine resolve most eyelid twitches within days. If you have recently had a dose increase, give your body a little time to adjust before attributing a new symptom to the medicine. Keeping a brief note of when the twitch occurs, how long it lasts and what else is going on (sleep, stress, screen hours) can be genuinely useful if you do speak to a clinician.
Do contact your prescriber if the symptom is worrying you or persisting. At nume, aftercare is available seven days a week, you do not need to wait for a formal appointment. For questions about what Wegovy is, how it works, and what the full side-effect profile looks like in the clinical trial data, the Wegovy overview page covers the medicine in detail. There is also a dedicated page specifically examining the question of whether Wegovy causes eye twitching if you want a more focused answer to that particular question.
For anyone considering semaglutide and weighing up what they might experience, understanding the genuine side-effect picture matters more than reassurance. If you are curious about whether Wegovy makes you itch, that is another reported sensation some people ask about and we cover it in detail on its own page. If you are curious about how Wegovy compares in cost terms to other options, the Wegovy price comparison page sets out UK context honestly. And if you are ready to talk to a prescriber about whether Wegovy is right for you, the place to start is a free consultation with our clinical team, no waiting list, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.